Ashurst advised Biotest AG as transaction counsel on its successful capital increase with subscription rights from authorised capital. The gross issue proceeds from the capital increase amount to approximately €76 million. The company plans to use the proceeds to create and extend new production capacities at its main production site in Dreieich, near Frankfurt. equinet Bank AG acted as sole global coordinator in the transaction.

Sydney: Leading international law firm Clifford Chance has advised RBS Morgans and Petra Capital in their capacity as joint lead managers on the successful A$22 million capital raising completed by Ingenia Communities Group.

Ingenia is a leading owner, operator and developer of seniors' housing communities in Australia.  Proceeds of the raising will be used to fund acquisitions of managed home estates.

Partner Lance Sacks led the Clifford Chance team advising the joint lead managers, assisted by associate Owen Thomas.

Global legal practice Norton Rose Fulbright has advised J.P. Morgan and Numis as joint bookrunners and corporate brokers on The UNITE Group plc's £51.2 million fundraising.

The transaction, which involved a cash box placing to existing and new institutional investors, was announced on June 13, 2013 and dealings in the new shares commenced today, June 18.

A tax and corporate team, led by tax partner Kathleen Russ and corporate partner Edmund Reed, have advised Partnership Assurance Group Plc ("PAG") and its management team on matters relating to management shareholders and option holders in connection with the company's listing on the main market of the London Stock Exchange on 12 June 2013 and an IPO involving the sale of shares by the management team and funds managed by Cinven.

Addleshaw Goddard's Corporate Finance team in Manchester has advised international mobile solutions company, 2ergo Group plc, on its £3.1m placing of shares. The deal will also see major changes to 2ergo's board of directors.

Osborne Clarke has advised its longstanding client The UNITE Group plc, the UK's leading developer and manager of student accommodation on its successful £51.2 million placing.

The Osborne Clarke team was led by Partner, Jonathan King, assisted by Senior Associate, Mark Wesker.

Nabarro is advising existing client Numis Securities on a £25.5 million placing to raise additional capital for AIM-traded Retroscreen Virology.

International law firm Pinsent Masons has advised antiviral anti-viral clinical trial specialist, Retroscreen, on its conditional placing raising a total of £25.5 million.

The firm, lead by corporate partner Russell Booker and associate Mark Stephens advised the AIM-listed company which is expected to use the funds to build a new clinical division.

Retroscreen is a virology healthcare business which provides clinical and pre-clinical analytical services for flu and cold antiviral products to global pharmaceutical and biotechnology organisations.

Valneva, the new fully integrated European biotech company created in 2013 through the merger between Vivalis and Intercell, has announced the launch of a fully underwritten €40 million capital increase with preferential subscription rights.

Field Fisher Waterhouse advised Versarien plc on its admission to the Alternative Investment Market (AIM) of the London Stock Exchange and the acquisition of Total Carbide Limited.